Overall rank by patents
#7,977
of 50,000 tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
ARK Therapeutic Services, Inc.
USPTO PatentsView assignee record - 40 granted patents across 0 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.
40
Total patents granted
0
CPC technology areas
1.0
Avg claims per patent
+800%
5-year grant velocity
The verdict
According to USPTO PatentsView, ARK ranks #7,977 of 50,000 tracked US assignees by granted-patent volume, with 40 patents across 0 technology areas.
- #7,977
- of 50,000 US assignees by volume
- Top 90%
- by Innovation Score (22.4/100)
- 1.0
- avg claims per patent
- +800%
- grant velocity, last 5 yrs
Portfolio overview
ARK Therapeutic Services, Inc. has been granted 40 US utility patents between 2019 and 2024, placing ARK Therapeutic Services, Inc. at #7,977 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 0 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.0 claims per patent. As a US Corporation, ARK Therapeutic Services, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, ARK sits between Alios Biopharma, Inc. (40 patents, rank #7,970) and Advanced Architectural Products, Llc (40 patents, rank #7,978) - the closest US assignees by grant volume. The composite Innovation Score of 22.4/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 36 grants, compared with 4 in the 2015–2019 window, a +800% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. ARK Therapeutic Services, Inc.'s 1.0 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 0 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Who files at ARK's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Alios Biopharma
ALIOS BIOPHARMA, INC.
40 patents
- Amcor Rigid Packa…
AMCOR RIGID PACKAGING USA, LLC
40 patents
- Anchor Hocking
ANCHOR HOCKING, LLC
40 patents
- AR & NS Investment
AR & NS Investment, LLC
40 patents
- Automated Assembly
AUTOMATED ASSEMBLY CORPORATION
40 patents
- Azurity Pharmaceu…
AZURITY PHARMACEUTICALS, INC.
40 patents
- Activevideo Netwo…
ActiveVideo Networks, LLC
40 patents
- Advanced Architec…
Advanced Architectural Products, LLC
40 patents
- ARK Therapeutic S… ◀
ARK Therapeutic Services, Inc.
40 patents
What this shows ARK holds 40 patents at rank #7,974, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near ARK
By rank, the assignees closest to #7,974 in granted patent volume.
- Alios Biopharma, Inc. #7,970 · 40 patents
- Amcor Rigid Packaging USA, Llc #7,971 · 40 patents
- Anchor Hocking, Llc #7,972 · 40 patents
- AR & NS Investment, Llc #7,973 · 40 patents
- Automated Assembly Corporation #7,975 · 40 patents
- Azurity Pharmaceuticals, Inc. #7,976 · 40 patents
- Activevideo Networks, Llc #7,977 · 40 patents
- Advanced Architectural Products, Llc #7,978 · 40 patents
ARK's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
22 Top 90% higher than 10% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 4 | 10.0% |
| 2020 | 3 | 7.5% |
| 2021 | 10 | 25.0% |
| 2022 | 4 | 10.0% |
| 2023 | 18 | 45.0% |
| 2024 | 1 | 2.5% |
Grant record at a glance
Portfolio Volume 40 grants
CPC subclasses 0
Avg. claims / grant 1.0
Velocity +800%
Historical grant data only; it does not rate legal strength or current strategy.
Frequently Asked Questions
Where does ARK Therapeutic Services, Inc. rank among US patent assignees?
According to USPTO PatentsView (2015–2025 granted utility patents), ARK Therapeutic Services, Inc. ranks #7,977 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.
How many patents does ARK Therapeutic Services, Inc. hold?
ARK Therapeutic Services, Inc. holds 40 US utility patents granted between 2019 and 2024, spanning 0 technology areas.
What is ARK Therapeutic Services, Inc.'s Innovation Score?
ARK Therapeutic Services, Inc. has an Innovation Score of 22.4 out of 100 (top 90% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does ARK Therapeutic Services, Inc. focus on?
ARK Therapeutic Services, Inc. holds grants across 0 technology areas classified under the Cooperative Patent Classification system.
Is ARK Therapeutic Services, Inc.'s patent grant rate increasing or decreasing?
ARK Therapeutic Services, Inc.'s recent grant velocity is +800% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.
What does claim depth mean for ARK Therapeutic Services, Inc.'s patents?
ARK Therapeutic Services, Inc.'s patents average 1.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.
How is the ARK Therapeutic Services, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
ARK's 40 grants land it in the top 90% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - ARK ranks #7,977 of 50,000. Top 50 holders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.